These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1428031)

  • 1. Magnetic resonance imaging in pancreatic diseases: comparison with other imaging techniques.
    Sood GK; Gupta RK; Broor SL
    Indian J Gastroenterol; 1992 Apr; 11(2):59-61. PubMed ID: 1428031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Predictive value of tomographic images in pancreatic diseases].
    Marincek B
    Schweiz Rundsch Med Prax; 1994 Jul; 83(29-30):823-7. PubMed ID: 8052772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the morphologic diagnosis of pancreatic disease.
    Swobodnik W; Meyer W; Brecht-Kraus D; Wechsler JG; Geiger S; Malfertheiner P; Junge U; Ditschuneit H
    Klin Wochenschr; 1983 Mar; 61(6):291-6. PubMed ID: 6865263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic disease: prospective comparison of CT, ERCP, and 1.5-T MR imaging with dynamic gadolinium enhancement and fat suppression.
    Semelka RC; Kroeker MA; Shoenut JP; Kroeker R; Yaffe CS; Micflikier AB
    Radiology; 1991 Dec; 181(3):785-91. PubMed ID: 1947098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic imaging. Computed tomography and magnetic resonance imaging.
    Thoeni RF; Blankenberg F
    Radiol Clin North Am; 1993 Sep; 31(5):1085-113. PubMed ID: 8395697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance (MR) in the diagnosis of pancreatic disease.
    Anacker H; Rupp N; Reiser M
    Eur J Radiol; 1984 Nov; 4(4):265-9. PubMed ID: 6519059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of magnetic resonance cholangiopancreatography for the diagnosis of cystic tumor of the pancreas compared with endoscopic retrograde cholangiopancreatography and computed tomography.
    Mera K; Tajiri H; Muto M; Ohtsu A; Furuse J; Maru Y; Kinoshita T; Ryu M; Nawano S; Murakami K; Moriyama N; Yoshida S
    Jpn J Clin Oncol; 1999 Jun; 29(6):294-8. PubMed ID: 10418558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of secretin-enhanced magnetic resonance cholangiopancreatography (S-MRCP) after unsuccessful endoscopic retrograde cholangiopancreatography (ERCP)].
    Czakó L; Takács T; Morvay Z; Csernay L; Lonovics J
    Orv Hetil; 2004 Mar; 145(10):529-34. PubMed ID: 15085592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic imaging.
    Clark LR; Jaffe MH; Choyke PL; Grant EG; Zeman RK
    Radiol Clin North Am; 1985 Sep; 23(3):489-501. PubMed ID: 2997833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging of the pancreas.
    Pamuklar E; Semelka RC
    Magn Reson Imaging Clin N Am; 2005 May; 13(2):313-30. PubMed ID: 15935314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early detection of pancreatic diseases. Practical consequences].
    Domschke W; Domschke S; Lux G
    Fortschr Med; 1983 Jul; 101(26):1219-23. PubMed ID: 6884958
    [No Abstract]   [Full Text] [Related]  

  • 12. Computed tomography and magnetic resonance imaging in the assessment of pancreatic disease.
    Keogan MT; Baker ME
    Gastrointest Endosc Clin N Am; 1995 Jan; 5(1):31-59. PubMed ID: 7728349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of endoscopic retrograde and magnetic resonance cholangiopancreatography in the surgical diagnosis of pancreatic diseases.
    Yamaguchi K; Chijiwa K; Shimizu S; Yokohata K; Morisaki T; Tanaka M
    Am J Surg; 1998 Mar; 175(3):203-8. PubMed ID: 9560120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma of the pancreatic ducts: comparative evaluation with CT and MR imaging at 1.5 T.
    Vellet AD; Romano W; Bach DB; Passi RB; Taves DH; Munk PL
    Radiology; 1992 Apr; 183(1):87-95. PubMed ID: 1312736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma.
    Balci NC; Semelka RC
    Eur J Radiol; 2001 May; 38(2):105-12. PubMed ID: 11335092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune pancreatitis in the context of IgG4-related disease: review of imaging findings.
    Lee LK; Sahani DV
    World J Gastroenterol; 2014 Nov; 20(41):15177-89. PubMed ID: 25386067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic imaging: current and emerging technologies.
    Nichols MT; Russ PD; Chen YK
    Pancreas; 2006 Oct; 33(3):211-20. PubMed ID: 17003640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic head mass: what can be done? Diagnosis: ERCP and EUS.
    Cipolletta L; Bianco MA; Rotondano G; Marmo R
    JOP; 2000 Sep; 1(3 Suppl):108-10. PubMed ID: 11854566
    [No Abstract]   [Full Text] [Related]  

  • 19. MR-cholangiopancreaticography (MRCP) and MR-angiography: morphologic changes with magnetic resonance imaging.
    Vahldiek G; Broemel T; Klapdor R
    Anticancer Res; 1999; 19(4A):2451-8. PubMed ID: 10470174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of imaging in pancreatic diseases.
    Kalra MK; Maher MM; Sahani DV; Digmurthy S; Saini S
    J Comput Assist Tomogr; 2002; 26(5):661-75. PubMed ID: 12439296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.